Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Switzerland’s Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials

Basel-based Nouscom, a clinical-stage, cancer interception focused BioTech developing next-generation immunotherapies, today announced the closing of an oversubscribed €120 million ($135 million) Series D financing to fund the advancement of an investigational off-the-shelf neoantigen-based cancer immunotherapy. The round was co-led by M Ventures and Revelation Partners alongside new investors…

Switzerland’s Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials

We haven't written up this one. EU-Startups has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at eu-startups.com →

More in Health & Medicine

Ebola can look like malaria: MoH warns as cases hit 8

NAIROBI, Kenya Oct 19 – The Ministry of Health has warned Kenyans that Ebola can initially look like malaria, urging anyone who feels unwell to seek medical care promptly as…

  • Ebola symptoms can initially resemble malaria
  • Ministry warns Kenyans to seek medical attention promptly
  • Eight Ebola cases confirmed in Kenya

More from Monday 19 October →